WO2007029156A3 - Isoindoledione derivatives as adrenergic receptor antagonists - Google Patents
Isoindoledione derivatives as adrenergic receptor antagonists Download PDFInfo
- Publication number
- WO2007029156A3 WO2007029156A3 PCT/IB2006/053082 IB2006053082W WO2007029156A3 WO 2007029156 A3 WO2007029156 A3 WO 2007029156A3 IB 2006053082 W IB2006053082 W IB 2006053082W WO 2007029156 A3 WO2007029156 A3 WO 2007029156A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bph
- isoindoledione
- derivatives
- receptor antagonists
- adrenergic receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Provided are isoindoledione derivatives, which can be used of treating a disease or disorder mediated through αla and/or α1(1 adrenergic receptors. Compounds disclosed herein can be used of treating benign prostatic hyperplasia (BPH) and related symptoms thereof, lower urinary tract symptoms (LUTS) associated with or without BPH. Processes for the preparation of described compounds, pharmaceutical compositions thereof, and methods of treating BPH and related symptoms thereof, LUTS associated with or without BPH are also provided.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2369/DEL/2005 | 2005-09-05 | ||
IN2369DE2005 | 2005-09-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007029156A2 WO2007029156A2 (en) | 2007-03-15 |
WO2007029156A3 true WO2007029156A3 (en) | 2007-09-07 |
Family
ID=37708296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2006/053082 WO2007029156A2 (en) | 2005-09-05 | 2006-09-01 | Isoindoledione derivatives as adrenergic receptor antagonists |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007029156A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019152946A1 (en) | 2018-02-05 | 2019-08-08 | Alkermes, Inc. | Compounds for the treatment of pain |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998051298A1 (en) * | 1997-05-12 | 1998-11-19 | Ortho-Mcneil Pharmaceutical Inc. | Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia |
US6245773B1 (en) * | 1996-05-16 | 2001-06-12 | Synaptic Pharmaceutical Corporation | 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines |
WO2002044151A1 (en) * | 2000-11-30 | 2002-06-06 | Ranbaxy Laboratories Limited | 1,4-disubstituted piperazine derivatives useful as uro-selective $g(a)1-adrenoceptor blockers |
WO2003084928A1 (en) * | 2002-04-08 | 2003-10-16 | Ranbaxy Laboratories Limited | Alpha, omega-dicarboximide derivatives as useful uro-selective α1α adrenoceptor blockers |
WO2005037281A1 (en) * | 2003-10-15 | 2005-04-28 | Ranbaxy Laboratories Limited | 1-alkylpiperazinyl-pyrrolidin-2, 5-dione derivatives as adrenergic receptor antagonist |
-
2006
- 2006-09-01 WO PCT/IB2006/053082 patent/WO2007029156A2/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6245773B1 (en) * | 1996-05-16 | 2001-06-12 | Synaptic Pharmaceutical Corporation | 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines |
WO1998051298A1 (en) * | 1997-05-12 | 1998-11-19 | Ortho-Mcneil Pharmaceutical Inc. | Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia |
WO2002044151A1 (en) * | 2000-11-30 | 2002-06-06 | Ranbaxy Laboratories Limited | 1,4-disubstituted piperazine derivatives useful as uro-selective $g(a)1-adrenoceptor blockers |
WO2003084928A1 (en) * | 2002-04-08 | 2003-10-16 | Ranbaxy Laboratories Limited | Alpha, omega-dicarboximide derivatives as useful uro-selective α1α adrenoceptor blockers |
WO2005037281A1 (en) * | 2003-10-15 | 2005-04-28 | Ranbaxy Laboratories Limited | 1-alkylpiperazinyl-pyrrolidin-2, 5-dione derivatives as adrenergic receptor antagonist |
WO2005037282A1 (en) * | 2003-10-15 | 2005-04-28 | Ranbaxy Laboratories Limited | 1-alkylpiperazinyl-pyrrolidin-2,5-dione derivatives as adrenergic receptor antagonists |
Also Published As
Publication number | Publication date |
---|---|
WO2007029156A2 (en) | 2007-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005074598A3 (en) | Nitroxyl progenitor compounds and methods of use | |
WO2007022257A3 (en) | Monocyclic and bicyclic compounds and methods of use | |
CA2334460A1 (en) | Pharmaceutical compositions comprising alpha-adrenoceptor antagonists and muscarinic antagonists | |
WO2007076070A3 (en) | Modulators of muscarinic receptors | |
WO2006113140A3 (en) | Novel compounds useful for bradykinin b1 receptor antagonism | |
WO2007073432A3 (en) | Piperidine derivatives and methods of use | |
WO2006044504A8 (en) | Cgrp receptor antagonists | |
WO2008082613A3 (en) | Factor ix moiety-polymer conjugates having a releasable linkage | |
WO2009140642A3 (en) | Tricyclic antagonists of prostaglandin d2 receptors | |
WO2008063202A3 (en) | Heterobicyclic thiophene compounds for the treatment of cancer | |
WO2002053533A3 (en) | Kappa opioid receptor ligands | |
WO2005117872A3 (en) | Dual acting snri-nmda antagonists for the treatment of genitourinary disorders | |
WO2006099268A3 (en) | Cgrp receptor antagonists | |
EP2206719A3 (en) | Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens: Synthesis, In Vitro Biological Activities, Pharmacokinetics and Antitumor | |
WO2007003411A3 (en) | Kinin antagonists for treating bladder dysfunction | |
WO2007039075A3 (en) | Pde inhibitors and combinations thereof for the treatment of urological disorders | |
WO2008005345A3 (en) | Compositions of 5-ht3 antagonists and dopamine d2 antagonists for treatment of dopamine-associated chronic conditions | |
WO2006047196A3 (en) | Cgrp receptor antagonists | |
WO2005072308A3 (en) | Cgrp receptor antagonists | |
WO2005112916A3 (en) | Bis-aryl sulfonamides | |
WO2006023852A3 (en) | Modulators of muscarinic receptors | |
WO2007079214A3 (en) | Prokineticin 2 receptor antagonists | |
WO2006065722A3 (en) | Compositions and methods for pulmonary conditions | |
WO2007061692A3 (en) | Spirolactam tricyclic cgrp receptor antagonists | |
WO2007025303A3 (en) | Non-steroidal antiandrogens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06795885 Country of ref document: EP Kind code of ref document: A2 |